Surfactant treatment of an infant with acute idiopathic pulmonary hemorrhage
Related Experiment Video
Updated: Jul 5, 2026

Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome (ARDS)
Published on: April 7, 2021
Tara M Neumayr1, Andrea M Watson, Mark E Wylam
1Department of Pediatrics, Mayo Clinic College of Medicine, Rochester, MN, USA.
Insights
Surfactant therapy successfully treated respiratory distress in a 4-week-old infant with pulmonary hemorrhage. This approach may help infants avoid more intensive treatments like ECMO.
Area of Science:
- Neonatal Medicine
- Pediatric Critical Care
- Respiratory Physiology
Background:
- Pulmonary hemorrhage is a rare but serious condition in infants.
- Respiratory distress can be refractory to conventional mechanical ventilation.
Observation:
- A 4-week-old infant presented with severe respiratory distress due to pulmonary hemorrhage.
- The infant's condition did not improve with standard mechanical ventilation.
Findings:
- Surfactant administration led to a 50% reduction in the oxygenation index.
- The infant showed clinical improvement and was successfully extubated.
Implications:
- Surfactant therapy is a potential treatment for pulmonary hemorrhage in infants.
- Early surfactant use may prevent the need for advanced respiratory support such as high-frequency oscillation ventilation or ECMO.
Objective:
To describe the successful use of surfactant for treatment of respiratory distress refractory to conventional mechanical ventilation in a 4-wk-old with pulmonary hemorrhage.
Design:
Case report.
Setting:
Tertiary care center pediatric intensive care unit.
Patient:
Four-week-old infant.
Main Result:
Clinical improvement of respiratory distress as evidenced by 50% reduction in oxygenation index and subsequent extubation.
Conclusion:
Pulmonary hemorrhage is a rare but potentially fatal condition in children. Previously described therapeutic approaches include high-frequency oscillation ventilation and extracorporeal membrane oxygenation. Infants with pulmonary hemorrhage and respiratory distress may benefit from a trial of surfactant before escalating care.
Related Concept Videos
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Breathing
Pulmonary Cycle: Exhalation
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Flail Chest-II
Assessment:
1. Clinical Evaluation:
History:
Respiratory Syncytial Virus Disease

